Works by Bendell, Johanna
Results: 99
Phase 1 study of cardiac safety of TAS-102 in patients with advanced solid tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A phase I dose escalation study of NK012, an SN-38 incorporating macromolecular polymeric micelle.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Erratum to: Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer.
- Published in:
- 2016
- By:
- Publication type:
- corrected article
Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A phase I open-label trial evaluating the cardiovascular safety of regorafenib in patients with advanced cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Anal Cancer: An Overview.
- Published in:
- Oncologist, 2007, v. 12, n. 5, p. 524, doi. 10.1634/theoncologist.12-5-524
- By:
- Publication type:
- Article
Regorafenib Prior to Selective Internal Radiation Therapy Using <sup>90</sup>Y-Resin Microspheres for Refractory Metastatic Colorectal Cancer Liver Metastases: Analysis of Safety, Dosimetry, and Molecular Markers.
- Published in:
- Frontiers in Oncology, 2019, p. 1, doi. 10.3389/fonc.2019.00624
- By:
- Publication type:
- Article
A phase 2 study of an oral mTORC1/mTORC2 kinase inhibitor (CC-223) for non-pancreatic neuroendocrine tumors with or without carcinoid symptoms.
- Published in:
- PLoS ONE, 2019, v. 14, n. 9, p. 1, doi. 10.1371/journal.pone.0221994
- By:
- Publication type:
- Article
A Phase 2 Study of 5-Fluorouracil (5-FU), Ziv-Aflibercept, and Radiation for the Preoperative and Adjuvant Treatment of Patients with Stage II/III Rectal Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Phase II Study of the c-Met Inhibitor Tivantinib in Combination with FOLFOX for the Treatment of Patients with Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction, or Stomach.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Phase-2 Trial of Single Agent Axitinib as Maintenance Therapy Following First-Line Treatment With Modified FOLFOX/Bevacizumab in Patients With Metastatic Colorectal Cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Phase 2 Study of the Hsp90 Inhibitor AUY922 as Treatment for Patients with Refractory Gastrointestinal Stromal Tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Phase II Study of the Combination of Bevacizumab, Pertuzumab, and Octreotide LAR for Patients with Advanced Neuroendocrine Cancers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Phase I Study of the Hsp90 Inhibitor AUY922 plus Capecitabine for the Treatment of Patients with Advanced Solid Tumors.
- Published in:
- 2015
- By:
- Publication type:
- journal article
A Phase II Trial of Preoperative Concurrent Chemotherapy/Radiation Therapy Plus Bevacizumab/Erlotinib in the Treatment of Localized Esophageal Cancer.
- Published in:
- Clinical Advances in Hematology & Oncology, 2012, v. 10, n. 7, p. 430
- By:
- Publication type:
- Article
Lenalidomide in combination with gemcitabine as first-line treatment for patients with metastatic carcinoma of the pancreas.
- Published in:
- Cancer Biology & Therapy, 2013, v. 14, n. 4, p. 340, doi. 10.4161/cbt.23625
- By:
- Publication type:
- Article
Phase I/II sequencing study of azacitidine, epacadostat, and pembrolizumab in advanced solid tumors.
- Published in:
- British Journal of Cancer, 2023, v. 128, n. 12, p. 2227, doi. 10.1038/s41416-023-02267-1
- By:
- Publication type:
- Article
First-in-human, dose-escalation, phase 1 study of anti-angiopoietin-2 LY3127804 as monotherapy and in combination with ramucirumab in patients with advanced solid tumours.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Impact of race on dose selection of molecular-targeted agents in early-phase oncology trials.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase 2 trial of trifluridine/tipiracil plus nivolumab in patients with heavily pretreated microsatellite‐stable metastatic colorectal cancer.
- Published in:
- Cancer Medicine, 2021, v. 10, n. 4, p. 1183, doi. 10.1002/cam4.3630
- By:
- Publication type:
- Article
A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 11, p. 5148, doi. 10.1002/cam4.2425
- By:
- Publication type:
- Article
Randomized, double‐blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer.
- Published in:
- Cancer Medicine, 2018, v. 7, n. 11, p. 5382, doi. 10.1002/cam4.1703
- By:
- Publication type:
- Article
First-In-Human Phase I Study Of A Dual mTOR Kinase And DNA-PK Inhibitor (CC-115) In Advanced Malignancy.
- Published in:
- Cancer Management & Research, 2019, v. 11, p. 10463, doi. 10.2147/CMAR.S208720
- By:
- Publication type:
- Article
Phase I dose-escalation study of tezacitabine in combination with 5-fluorouracil in patients with advanced solid tumors.
- Published in:
- Cancer (0008543X), 2005, v. 103, n. 9, p. 1925, doi. 10.1002/cncr.21002
- By:
- Publication type:
- Article
Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.
- Published in:
- Cancer (0008543X), 2003, v. 97, n. 12, p. 2972
- By:
- Publication type:
- Article
A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma.
- Published in:
- Oncology, 2018, v. 94, n. 6, p. 329, doi. 10.1159/000485384
- By:
- Publication type:
- Article
Costs Associated with Capecitabine or 5-Fluorouracil Monotherapy after Surgical Resection in Patients with Colorectal Cancer.
- Published in:
- Oncology, 2009, v. 77, n. 3/4, p. 244, doi. 10.1159/000236048
- By:
- Publication type:
- Article
Predictive potential of angiopoietin-2 in a mCRC subpopulation treated with vanucizumab in the McCAVE trial.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1157596
- By:
- Publication type:
- Article
Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma.
- Published in:
- Nature Communications, 2016, v. 7, n. 8, p. 12624, doi. 10.1038/ncomms12624
- By:
- Publication type:
- Article
Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Evolving Diagnostic and Treatment Strategies for Pancreatic Neuroendocrine Tumors.
- Published in:
- Journal of Hematology & Oncology, 2011, v. 4, n. 1, p. 29, doi. 10.1186/1756-8722-4-29
- By:
- Publication type:
- Article
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 5, p. 966, doi. 10.1002/cncr.34016
- By:
- Publication type:
- Article
A phase I dose-escalation study to assess safety, tolerability, pharmacokinetics, and preliminary efficacy of the dual mTORC1/mTORC2 kinase inhibitor CC-223 in patients with advanced solid tumors or multiple myeloma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Phase 1, open-label, dose escalation, safety, and pharmacokinetics study of ME-344 as a single agent in patients with refractory solid tumors.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 7, p. 1056, doi. 10.1002/cncr.29155
- By:
- Publication type:
- Article
Napabucasin Plus FOLFIRI in Patients With Previously Treated Metastatic Colorectal Cancer: Results From the Open-Label, Randomized Phase III CanStem303C Study.
- Published in:
- Clinical Colorectal Cancer, 2023, v. 22, n. 1, p. 100, doi. 10.1016/j.clcc.2022.11.002
- By:
- Publication type:
- Article
Axitinib or Bevacizumab Plus FOLFIRI or Modified FOLFOX-6 After Failure of First-Line Therapy for Metastatic Colorectal Cancer: A Randomized Phase II Study.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 4, p. 239, doi. 10.1016/j.clcc.2013.09.001
- By:
- Publication type:
- Article
Treatment Rationale and Study Design for a Randomized, Double-Blind, Placebo-Controlled Phase II Study Evaluating Onartuzumab (MetMAb) in Combination With Bevacizumab Plus mFOLFOX-6 in Patients With Previously Untreated Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2013, v. 12, n. 3, p. 218, doi. 10.1016/j.clcc.2013.04.001
- By:
- Publication type:
- Article
A Phase II Study of Oxaliplatin, Dose-intense Capecitabine, and High-dose Bevacizumab in the Treatment of Metastatic Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2011, v. 10, n. 3, p. 210, doi. 10.1016/j.clcc.2011.03.018
- By:
- Publication type:
- Article
Targeted Therapy in Rectal Cancer.
- Published in:
- Oncology (08909091), 2007, v. 21, n. 9, p. 1055
- By:
- Publication type:
- Article
Radiation Therapy for Resectable Colon Cancer.
- Published in:
- Oncology (08909091), 2006, v. 20, n. 2, p. 179
- By:
- Publication type:
- Article
Relative Bioavailability of Pediatric Oral Solution and Tablet Formulations of Trametinib in Adult Patients With Solid Tumors.
- Published in:
- Clinical Pharmacology in Drug Development, 2015, v. 4, n. 4, p. 287, doi. 10.1002/cpdd.152
- By:
- Publication type:
- Article
A randomized, placebo-controlled, phase 1/2 study of tivantinib (ARQ 197) in combination with irinotecan and cetuximab in patients with metastatic colorectal cancer with wild-type KRAS who have received first-line systemic therapy.
- Published in:
- International Journal of Cancer, 2016, v. 139, n. 1, p. 177, doi. 10.1002/ijc.30049
- By:
- Publication type:
- Article
Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-41618-7
- By:
- Publication type:
- Article
Phase 1 cohort expansion study of LY3023414, a dual PI3K/mTOR inhibitor, in patients with advanced mesothelioma.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 4, p. 1081, doi. 10.1007/s10637-021-01086-6
- By:
- Publication type:
- Article
A phase Ib open-label dose escalation study of the safety, pharmacokinetics, and pharmacodynamics of cobimetinib (GDC-0973) and ipatasertib (GDC-0068) in patients with locally advanced or metastatic solid tumors.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 163, doi. 10.1007/s10637-020-00975-6
- By:
- Publication type:
- Article
Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC).
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 182, doi. 10.1007/s10637-020-01000-6
- By:
- Publication type:
- Article
A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancer.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 4, p. 1145, doi. 10.1007/s10637-019-00873-6
- By:
- Publication type:
- Article
Phase Ib study of the MEK inhibitor cobimetinib (GDC-0973) in combination with the PI3K inhibitor pictilisib (GDC-0941) in patients with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2020, v. 38, n. 2, p. 419, doi. 10.1007/s10637-019-00776-6
- By:
- Publication type:
- Article
First-in-human study of the anti-HB-EGF antibody U3-1565 in subjects with advanced solid tumors.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 1, p. 147, doi. 10.1007/s10637-018-0646-1
- By:
- Publication type:
- Article